Unlike common antidepressants, which treat depression by increasing levels of neurotransmitters in areas of the brain that affect mood, and traditional Ketamine treatment, which requires an intravenous drip, SPRAVATO uses a concentrated nasal spray to target the NMDA receptor, and is believed to work differently than currently available prescription antidepressants. The result is fast, effective relief from severe symptoms of major depressive disorder (MDD).
SPRAVATO is only for adults suffering from severe symptoms of major depressive disorders, like suicidal ideation and behaviors, or those experiencing treatment-resistant depression, a condition which can only be evaluated and diagnosed by qualified medical professional. If you’ve tried two or more preliminary depression treatments, like talk therapy and prescription medications, or more advanced therapies like TMS or standard Ketamine therapy without sustained relief or positive results, SPRAVATO may be right for you.